|
|
Home | Search | Advance Search | Browse | Online Submission | Documentation & FAQ | Team | Contact us |
|
PolysacDB ID | 1517 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Klebsiella pneumoniae (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed functions | CPS have been shown to be important virulence factors and potent Ag for the induction of immunoprotection |
Antigenic Nature used to produce antibodies | A 24-valent K. pneumoniae CPS vaccine containing the serotypes 2, 3, 5, 9, 10, 15, 16. 17, 18, 21, 22, 25, 28. 30, 35, 43, 52, 53, 55, 60, 61, 62, 63, and 64 |
Carrier Name | Nil |
Conjugation Method | Nil |
Antibodies | Mab MT 74 H31 |
Antibody type and class | IgA |
Assay System | ELISA and immunofluorescence |
Cross-reactivity | This Mab recognised K16 and K17 strains |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab may prove valuable as diagnostic tools and that an immunotherapy is feasible |
Curator ID | AA + AS |
Date of Curation | 10-08-2010 |
References | 2016541 |
PolysacDB ID | 1518 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Klebsiella pneumoniae (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed functions | CPS have been shown to be important virulence factors and potent Ag for the induction of immunoprotection |
Antigenic Nature used to produce antibodies | A 24-valent K. pneumoniae CPS vaccine containing the serotypes 2, 3, 5, 9, 10, 15, 16. 17, 18, 21, 22, 25, 28. 30, 35, 43, 52, 53, 55, 60, 61, 62, 63, and 64 |
Carrier Name | Nil |
Conjugation Method | Nil |
Antibodies | Mab S3-4H68 |
Antibody type and class | IgM |
Assay System | ELISA and immunofluorescence |
Cross-reactivity | This Mab recognised K26, K30 and K69 strains |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab may prove valuable as diagnostic tools and that an immunotherapy is feasible |
Curator ID | AA + AS |
Date of Curation | 19-08-2010 |
References | 2016541 |
PolysacDB ID | 1519 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Klebsiella pneumoniae (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed functions | CPS have been shown to be important virulence factors and potent Ag for the induction of immunoprotection |
Antigenic Nature used to produce antibodies | A 24-valent K. pneumoniae CPS vaccine containing the serotypes 2, 3, 5, 9, 10, 15, 16. 17, 18, 21, 22, 25, 28. 30, 35, 43, 52, 53, 55, 60, 61, 62, 63, and 64 |
Carrier Name | Nil |
Conjugation Method | Nil |
Antibodies | Mab KJ6-1H74 |
Antibody type and class | IgM |
Assay System | ELISA and immunofluorescence |
Cross-reactivity | This Mab recognised K30, K82 and K69 strains |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab may prove valuable as diagnostic tools and that an immunotherapy is feasible |
Curator ID | AA + AS |
Date of Curation | 19-08-2010 |
References | 2016541 |
PolysacDB ID | 1520 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Klebsiella pneumoniae (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed functions | CPS have been shown to be important virulence factors and potent Ag for the induction of immunoprotection |
Antigenic Nature used to produce antibodies | A 24-valent K. pneumoniae CPS vaccine containing the serotypes 2, 3, 5, 9, 10, 15, 16. 17, 18, 21, 22, 25, 28. 30, 35, 43, 52, 53, 55, 60, 61, 62, 63, and 64 |
Carrier Name | Nil |
Conjugation Method | Nil |
Antibodies | Mab MT133 H26 |
Antibody type and class | IgM |
Assay System | ELISA and immunofluorescence |
Cross-reactivity | This Mab recognised K16 and K17 strains |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab may prove valuable as diagnostic tools and that an immunotherapy is feasible |
Curator ID | AA + AS |
Date of Curation | 20-08-2010 |
References | 2016541 |
PolysacDB ID | 1521 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Klebsiella pneumoniae (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed functions | CPS have been shown to be important virulence factors and potent Ag for the induction of immunoprotection |
Antigenic Nature used to produce antibodies | A 24-valent K. pneumoniae CPS vaccine containing the serotypes 2, 3, 5, 9, 10, 15, 16. 17, 18, 21, 22, 25, 28. 30, 35, 43, 52, 53, 55, 60, 61, 62, 63, and 64 |
Carrier Name | Nil |
Conjugation Method | Nil |
Antibodies | Mab MT71 H105 |
Antibody type and class | IgM |
Assay System | ELISA and immunofluorescence |
Cross-reactivity | This Mab recognised K55 strains |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab may prove valuable as diagnostic tools and that an immunotherapy is feasible |
Curator ID | AA + AS |
Date of Curation | 20-08-2010 |
References | 2016541 |
PolysacDB ID | 1522 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Klebsiella pneumoniae (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed functions | CPS have been shown to be important virulence factors and potent Ag for the induction of immunoprotection |
Antigenic Nature used to produce antibodies | A 24-valent K. pneumoniae CPS vaccine containing the serotypes 2, 3, 5, 9, 10, 15, 16. 17, 18, 21, 22, 25, 28. 30, 35, 43, 52, 53, 55, 60, 61, 62, 63, and 64 |
Carrier Name | Nil |
Conjugation Method | Nil |
Antibodies | Mab MT72 H99 |
Antibody type and class | IgM |
Assay System | ELISA and immunofluorescence |
Cross-reactivity | This Mab recognised K5, K6, K7, K10, K20, K49, K61, K62, K64 and K74 strains |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab may prove valuable as diagnostic tools and that an immunotherapy is feasible |
Curator ID | AA + AS |
Date of Curation | 21-08-2010 |
References | 2016541 |
PolysacDB ID | 1523 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Klebsiella pneumoniae (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed functions | CPS have been shown to be important virulence factors and potent Ag for the induction of immunoprotection |
Antigenic Nature used to produce antibodies | A 24-valent K. pneumoniae CPS vaccine containing the serotypes 2, 3, 5, 9, 10, 15, 16. 17, 18, 21, 22, 25, 28. 30, 35, 43, 52, 53, 55, 60, 61, 62, 63, and 64 |
Carrier Name | Nil |
Conjugation Method | Nil |
Antibodies | MT168 H11 |
Antibody type and class | IgA |
Assay System | ELISA and immunofluorescence |
Cross-reactivity | This Mab recognized K3, K68 and K46 |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab may prove valuable as diagnostic tools and that an immunotherapy is feasible |
Curator ID | AA + AS |
Date of Curation | 21-08-2010 |
References | 2016541 |
PolysacDB ID | 1524 |
Carbohydrate Name | Capsular polysaccharide (Drugpedia) |
Carbohydrate Class | Capsular polysaccharide |
Microbe | Klebsiella pneumoniae (NCBI Taxonomy) (Drugpedia) |
Basic Structure | N/A |
BCSDB Structure | N/A |
Proposed functions | CPS have been shown to be important virulence factors and potent Ag for the induction of immunoprotection |
Antigenic Nature used to produce antibodies | A 24-valent K. pneumoniae CPS vaccine containing the serotypes 2, 3, 5, 9, 10, 15, 16. 17, 18, 21, 22, 25, 28. 30, 35, 43, 52, 53, 55, 60, 61, 62, 63, and 64 |
Carrier Name | Nil |
Conjugation Method | Nil |
Antibodies | S2-A H92 |
Antibody type and class | IgA |
Assay System | ELISA and immunofluorescence |
Cross-reactivity | This Mab recognized K9, K79 and K81 strains |
Proposed epitopes | N/A |
IEDB Epitope | N/A |
Proposed Utility | This Mab may prove valuable as diagnostic tools and that an immunotherapy is feasible |
Curator ID | AA + AS |
Date of Curation | 22-08-2010 |
References | 2016541 |
Bioinformatics Centre, Institute of Microbial Technology, Sec - 39A, Chandigarh, India - 160036 |